Human alpha 1-proteinase inhibitor. Crystal structure analysis of two crystal modifications, molecular model and preliminary analysis of the implications for function.

No abstract is available for this paper.

• Publication year

  1984

• Venue

  Journal of Molecular Biology

• Publication date

  1984-08-15

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/0022-2836(84)90298-5PMID 6332197
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Translation and processing of normal (PiMM) and abnormal (PiZZ) human alpha 1-antitrypsin.

  1983cited by this paper
• Human plasma proteinase inhibitors.

  1983cited by this paper
• Translation and processing of normal (PiMM) and abnormal (PiZZ) human α1‐antitrypsin

  1983cited by this paper
• Gene and protein structure of a β-crystallin polypeptide in murine lens: relationship of exons and structural motifs

  1983cited by this paper
• alpha 1-Antitrypsin microheterogeneity. Isolation and physiological significance of isoforms.

  1982cited by this paper
• In vitro synthesis of M and Z forms of human α1‐antitrypsin

  1982cited by this paper
• The biosynthesis of rat alpha 1-antitrypsin.

  1982cited by this paper
• Sequence homology and structural comparison between the chromosomal human α1-antitrypsin and chicken ovalbumin genes

  1982cited by this paper
• Structure and variation of human α1–antitrypsin

  1982cited by this paper
• Computer-generated schematic diagrams of protein structures.

  1982cited by this paper
• Crystallographic refinement of Japanese quail ovomucoid, a Kazal-type inhibitor, and model building studies of complexes with serine proteases.

  1982cited by this paper
• Three-dimensional structure of the complex between pancreatic secretory trypsin inhibitor (Kazal type) and trypsinogen at 1.8 A resolution. Structure solution, crystallographic refinement and preliminary structural interpretation.

  1982cited by this paper
• Interaction of human alpha 1-proteinase inhibitor with chymotrypsinogen A and crystallization of a proteolytically modified alpha 1-proteinase inhibitor.

  1982cited by this paper
• Potential mechanism of emphysema: alpha 1-proteinase inhibitor recovered from lungs of cigarette smokers contains oxidized methionine and has decreased elastase inhibitory capacity.

  1982cited by this paper
• Three-dimensional structure of the complex between pancreatic secretory trypsin inhibitor (Kazal type) and trypsinogen at 1.8 A resolution. Structure solution, crystallographic refinement and preliminary structural interpretation.

  1982cited by this paper
• Cloning and sequence of cDNA coding for alpha 1-antitrypsin.

  1981cited by this paper
• Human α1‐antitrypsin: carbohydrate attachment and sequence homology

  1981cited by this paper
• Human alpha 1-antitrypsin: carbohydrate attachment and sequence homology.

  1981cited by this paper
• Enzymatic reduction of oxidized alpha-1-proteinase inhibitor restores biological activity.

  1981cited by this paper
• Crystallographic refinement and atomic models of a human Fc fragment and its complex with fragment B of protein A from Staphylococcus aureus at 2.9- and 2.8-A resolution.

  1981cited by this paper
• Characterization of the oligosaccharides of liver Z variant alpha 1-antitrypsin.

  1980cited by this paper
• Kinetics of association of serine proteinases with native and oxidized alpha-1-proteinase inhibitor and alpha-1-antichymotrypsin.

  1980cited by this paper
• A surprising new protein superfamily containing ovalbumin, antithrombin-III, and alpha 1-proteinase inhibitor.

  1980cited by this paper
• Protein inhibitors of proteinases.

  1980cited by this paper
• Active site of alpha 1-antitrypsin: homologous site in antithrombin-III.

  1980cited by this paper
• Active site of α1-antitrypsin: Homologous site in antithrombin-III

  1980cited by this paper
• Cigarette smoking induces functional antiprotease deficiency in the lower respiratory tract of humans.

  1979cited by this paper
• Carboxy terminal fragment of human α-1-antitrypsin from hydroxylamine clevage: Homology with antithrombin III

  1979cited by this paper
• Carboxy terminal fragment of human alpha-1-antitrypsin from hydroxylamine cleavage: homology with antithrombin III.

  1979cited by this paper
• Characterization of the inactive fragment resulting from limited proteolysis of human alpha1-proteinase inhibitor by Crotalus adamanteus proteinase II.

  1979cited by this paper
• alpha1-Antitrypsin: the presence of excess mannose in the Z variant isolated from liver.

  1978cited by this paper
• Analysis of the accuracy and implications of simple methods for predicting the secondary structure of globular proteins.

  1978cited by this paper
• Refinement of Large Structures by Simultaneous Minimization of Energy and R Factor

  1978cited by this paper
• Structural basis of the activation and action of trypsin

  1978cited by this paper
• Why genes in pieces?

  1978cited by this paper
• Do genes-in-pieces imply proteins-in-pieces?

  1978cited by this paper
• Nucleotide sequence homology at 12 intron–exon junctions in the chick ovalbumin gene

  1978cited by this paper
• A graphics model building and refinement system for macromolecules

  1978cited by this paper
• Ovalbumin gene is split in chicken DNA

  1977cited by this paper
• Efficient structure-factor calculation for large molecules by the fast Fourier transform

  1977cited by this paper
• α‐1‐Antitrypsin: Sequence of the Z variant tryptic peptide

  1977cited by this paper
• alpha-1-Antitrypsin: sequence of the Z variant tryptic peptide.

  1977cited by this paper
• Methods and programs for direct‐space exploitation of geometric redundancies

  1976cited by this paper
• Crystallographic structural studies of a human Fc fragment. II. A complete model based on a Fourier map at 3.5 A resolution.

  1976cited by this paper
• The abnormality of the S variant of human α-1-antitrypsin

  1976cited by this paper
• Crystallographic structure studies of an IgG molecule and an Fc fragment

  1976cited by this paper
• Amino acid substitution Glu→Lys in α1‐antitrypsin PiZ

  1976cited by this paper
• Amino acid substitution Glu leads to Lys alpha1-antitrypsin PiZ.

  1976cited by this paper
• The abnormality of the S variant of human alpha-1-antitrypsin.

  1976cited by this paper
• Fluorescent antibody studies of alpha-1-antitrypsin in adult human lung.

  1975cited by this paper
• Alpha-1-antitrypsin content in the serum, alveolar macrophages, and alveolar lavage fluid of smoking and nonsmoking normal subjects.

  1975cited by this paper
• Characterization of α1-Antitrypsin in the Inclusion Bodies from the Liver in α1-Antitrypsin Deficiency

  1975cited by this paper
• Refinement of setting angles in screenless film methods

  1975cited by this paper
• Characterization of alpha1-antitrypsin in the inclusion bodies from the liver in alpha 1-antitrypsin deficiency.

  1975cited by this paper
• Crystallographic fast Fourier transforms

  1973cited by this paper
• The Case of the Ruptured Aorta

  1971cited by this paper
• Representation of phase probability distributions for simplified combination of independent phase information

  1970cited by this paper
• Cirrhosis associated with alpha-1-antitrypsin deficiency: a previously unrecognized inherited disorder.

  1969cited by this paper
• A case of inherited deficiency of serum alpha-antitrypsin associated with pulmonary emphysema.

  1966cited by this paper
• The Electrophoretic α;1-Globulin Pattern of Serum in α;1-Antitrypsin Deficiency

  1963cited by this paper

• Expression and purification of a broad-spectrum human protease inhibitor in Pichia pastoris

  2025cites this paper
• An endogenous human peptide derived from α1-antitrypsin as a novel pharmacological inhibitor of Bordetella pertussis toxin.

  2025cites this paper
• The mechanism of pathogenic α1-antitrypsin aggregation in the human liver

  2025cites this paper
• Activity of Serpins in Context to Hydrophobic Interaction

  2025cites this paper
• Exploring the Potential Impact of SERPINE Gene Expression in Cumulus Cells During Fertility Treatments: A Single Center Study

  2025cites this paper
• A novel pathological mutant reveals the role of torsional flexibility in the serpin breach in adoption of an aggregation‐prone intermediate

  2024cites this paper
• A novel in vitro cell model of the proteinase/antiproteinase balance observed in alpha-1 antitrypsin deficiency

  2024cites this paper
• Correlation of single nucleotide polymorphisms in the AGT gene with susceptibility to systemic lupus erythematosus in Northeast China

  2024cites this paper
• SERPINA1 long transcripts produce non-secretory alpha1-antitrypsin isoform: In vitro translation in living cells.

  2023cites this paper
• TMAO to the rescue of pathogenic protein variants.

  2022cites this paper
• Development of peptide ligands for the purification of α-1 antitrypsin from cell culture fluids.

  2022cites this paper
• Secretion of functional α1-antitrypsin is cell type dependent: Implications for intramuscular delivery for gene therapy

  2022cites this paper
• Transient response of serpinA3 during cellular stress

  2022cites this paper
• A Review of Alpha-1 Antitrypsin Binding Partners for Immune Regulation and Potential Therapeutic Application

  2022influential citation
• Stepwise Reversion of Multiply Mutated Recombinant Antitrypsin Reveals a Selective Inhibitor of Coagulation Factor XIa as Active as the M358R Variant

  2021cites this paper
• SepA Enhances Shigella Invasion of Epithelial Cells by Degrading Alpha-1 Antitrypsin and Producing a Neutrophil Chemoattractant

  2021cites this paper
• FTIR study of synthesised ovalbumin nanoparticles.

  2021cites this paper
• Extending the Horizon of Homology Detection with Coevolution-based Structure Prediction

  2021cites this paper
• A reactive center loop–based prediction platform to enhance the design of therapeutic SERPINs

  2021cites this paper
• Neuroserpin and transthyretin are extracellular chaperones that preferentially inhibit amyloid formation

  2021cites this paper
• Structure, Immunoreactivity, and In Silico Epitope Determination of SmSPI S. mansoni Serpin for Immunodiagnostic Application

  2021cites this paper
• Alpha‐1‐antitrypsin reduces inflammation and exerts chondroprotection in arthritis

  2021cites this paper
• Therapeutic SERPINs: Improving on Nature

  2021cites this paper
• High-resolution ex vivo NMR spectroscopy of human Z α1-antitrypsin

  2020cites this paper
• The effect of water/ethanol solvent mixtures on interactions of an antibody selective for wild-type alpha-1-antitrypsin in complex with its antigen

  2020cites this paper
• α1-antitrypsin PI*SZ genotype: a SERPINA1 deficiency haplotype with uncertain clinical and therapeutic implications

  2020cites this paper
• Gene therapy for alpha 1-antitrypsin deficiency with an oxidant-resistant human alpha 1-antitrypsin

  2020cites this paper
• Engineering the serpin α1‐antitrypsin: A diversity of goals and techniques

  2019cites this paper
• Bifidobacteria cell wall-derived exo-polysaccharides, lipoteichoic acids, peptidoglycans, polar lipids and proteins - Their chemical structure and biological attributes.

  2019cites this paper
• Thermostabilization of Ovalbumin for the Possible Implications of anby an Alkaline Altered Serpin JSBA Treatment : Examination Loop Structure

  2018cites this paper
• Pharmacoperones as Novel Therapeutics for Diverse Protein Conformational Diseases.

  2018cites this paper
• Plasma Proteolytic Cascade Activation during Neonatal Cardiopulmonary Bypass Surgery

  2018cites this paper
• The Manduca sexta serpinome: Analysis of serpin genes and proteins in the tobacco hornworm.

  2018cites this paper
• Antithrombin III.

  2018cites this paper
• Identification and partial characterization of a novel serpin from Eudiplozoon nipponicum (Monogenea, Polyopisthocotylea)

  2018cites this paper
• Plasminogen Activator Inhibitor 1 for Predicting Sepsis Severity and Mortality Outcomes: A Systematic Review and Meta-Analysis

  2018cites this paper
• Alpha1-Antitrypsin: Structure and Dynamics in Health, Disease and Drug Development

  2017cites this paper
• How serpins transport hormones and regulate their release.

  2017cites this paper
• Mesenchymal stem/stromal cells engineered to express the protease inhibitor alpha-1 antitrypsin for the treatment of inflammatory lung diseases

  2017cites this paper
• All-Atom Simulations Reveal How Single-Point Mutations Promote Serpin Misfolding.

  2017cites this paper
• Role of the P2 residue of human alpha 1-antitrypsin in determining target protease specificity

  2017cites this paper
• The Serpintine Solution

  2017cites this paper
• A structure-derived snap-trap mechanism of a multispecific serpin from the dysbiotic human oral microbiome

  2017cites this paper
• Evaluation d'un variant d'antithrombine dans différentes indications thérapeutiques

  2016cites this paper
• Molecular Mechanism of Z α1-Antitrypsin Deficiency*

  2016cites this paper
• Deficiência parcial da proteína transportadora de tiroxina (TBG) : estudo do gene serpina7 e padrão de inativação do cromossomo x em uma família brasileira

  2016cites this paper
• Chemistry and Biology in the Biosynthesis and Action of Thyroid Hormones.

  2016cites this paper
• Chemie und Biologie der Schilddrüsenhormon‐Biosynthese und ‐Wirkung

  2016cites this paper
• Alpha-1-Antitrypsin and the Serpins

  2016cites this paper
• Alpha-1 Antitrypsin: The Protein

  2016cites this paper
• 1.45 Å resolution structure of SRPN18 from the malaria vector Anopheles gambiae.

  2016cites this paper
• Vioserpin, a serine protease inhibitor from Gloeobacter violaceus possibly regulated by heparin.

  2016cites this paper
• Serpin A1 C‐Terminal Peptides as Collagen Turnover Modulators

  2016cites this paper
• Effects of the neutrophil elastase inhibitor EL-17 in rat adjuvant-induced arthritis.

  2016cites this paper
• The role of structural flexibility and stability in the interaction of serine proteases with their inhibitors.

  2015cites this paper
• Kinetics of trypsin-catalyzed hydrolysis determined by isothermal titration calorimetry.

  2015cites this paper
• Peptides as Modulators of Serpin Action

  2015cites this paper
• Characterisation of SerpinB2 as a stress response modulator

  2015cites this paper
• A single-chain variable fragment intrabody prevents intracellular polymerization of Z α1-antitrypsin while allowing its antiproteinase activity

  2015cites this paper
• Therapeutic targeting of misfolding and conformational change in α1-antitrypsin deficiency.

  2014cites this paper
• Phase I/II Study of Intrapleural Administration of a Serotype rh.10 Replication-Deficient Adeno-Associated Virus Gene Transfer Vector Expressing the Human α1-Antitrypsin cDNA to Individuals with α1-Antitrypsin Deficiency

  2014cites this paper
• The molecular and cellular pathology of α₁-antitrypsin deficiency.

  2014cites this paper
• Functional Stability of Plasminogen Activator Inhibitor-1

  2014cites this paper
• Vaspin inhibits kallikrein 7 by serpin mechanism

  2013cites this paper
• Isolierung und Charakterisierung hochaffiner Cystinknoten-basierter Matriptase-1 Inhibitoren

  2013cites this paper
• Structural characterization of Spinacia oleracea trypsin inhibitor III (SOTI-III).

  2013cites this paper
• "How I chose research on proteases or, more correctly, how it chose me".

  2013cites this paper
• Nematode Brugia malayi Inhibits Human Neutrophil Serine Proteinases A Novel Serpin Expressed by Blood-Borne Microfilariae of the Parasitic

  2013cites this paper
• “Wie ich zur Proteaseforschung kam oder, richtiger gesagt, wie die Proteaseforschung zu mir kam”

  2013cites this paper
• Twenty Years of Polymers: A Personal Perspective on Alpha-1 Antitrypsin Deficiency

  2013cites this paper
• The parallel lives of alpha1-antitrypsin deficiency and pulmonary alveolar proteinosis

  2013cites this paper
• Fusion of the C-terminal triskaidecapeptide of hirudin variant 3 to alpha1-proteinase inhibitor M358R increases the serpin-mediated rate of thrombin inhibition

  2013cites this paper
• Expression screening of bacterial libraries of recombinant alpha-1 proteinase inhibitor variants for candidates with thrombin inhibitory capacity.

  2013cites this paper
• Chemerin and Vaspin: Possible Targets to Treat Obesity?

  2013cites this paper
• Recombinant Technology in Hemostasis and Thrombosis

  2012cites this paper
• Polymerization and Oxidation of Alpha-1-Antitrypsin in Pathogenesis of Emphysema

  2012cites this paper
• STRUKTURNA I FUNKCIONALNA ANALIZA GENA ZA ALFA-1-ANTITRIPSIN U BOLESTIMA PLUĆA ČOVEKA

  2012cites this paper
• Alpha1‐Proteinase Inhibitor: The Disease, the Protein, and Commercial Production

  2012cites this paper
• Three-dimensional structure of a schistosome serpin revealing an unusual configuration of the helical subdomain.

  2012cites this paper
• Low Molecular Weight Antagonists of Plasminogen Activator Inhibitor-1: Therapeutic Potential in Cardiovascular Disease.

  2012cites this paper
• Mutagenesis of the bovSERPINA3‐3 demonstrates the requirement of aspartate‐371 for intermolecular interaction and formation of dimers

  2012cites this paper
• Crystallography of serpins and serpin complexes.

  2011cites this paper
• Regulation of proteases by protein inhibitors of the serpin superfamily.

  2011cites this paper
• Serpins as hormone carriers: modulation of release.

  2011cites this paper
• Mechanistic behaviour and molecular interactions of heat shock protein 47 (HSP47)

  2011cites this paper
• Allosteric Modulation of Hormone Release from Thyroxine and Corticosteroid-binding Globulins*

  2011cites this paper
• The role of novel transmembrane serine proteases : implications for arthritis

  2011cites this paper
• Serpin structure, function and dysfunction

  2011cites this paper
• Serpin polymerization in vitro.

  2011influential citation
• Consequences of Elastolysis

  2011cites this paper
• Solving serpin crystal structures.

  2011cites this paper
• Proprotein convertases and serine protease inhibitors : developing novel indirect-acting antiviral strategies against hepatitis c virus

  2011cites this paper
• Structural change in β-sheet A of Z α(1)-antitrypsin is responsible for accelerated polymerization and disease.

  2011cites this paper
• Molecular contortionism – on the physical limits of serpin ‘loop-sheet’ polymers

  2010influential citation
• Defining the mechanism of polymerization in the serpinopathies

  2010cites this paper
• Characterisation of the cellular roles of the non-inhibitory serpin, maspin

  2010cites this paper
• Control of granzymes by serpins

  2010cites this paper
• Loop-Sheet Mechanism of Serpin Polymerization Tested by Reactive Center Loop Mutations*

  2010cites this paper
• Molecular and Cellular Studies of Drosophila Neuroserpin Spn4A and its Polymer-Forming Mutants

  2010cites this paper
• Neutrophil Elastase, Proteinase 3, and Cathepsin G as Therapeutic Targets in Human Diseases

  2010cites this paper